Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study

Multiple Sclerosis and Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles